KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $419.0 million.

  • Quest Diagnostics' Free Cash Flow rose 67.60% to $419.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 36.17%. This contributed to the annual value of $909.0 million for FY2024, which is 5.21% up from last year.
  • Quest Diagnostics' Free Cash Flow amounted to $419.0 million in Q3 2025, which was down 3.90% from $436.0 million recorded in Q2 2025.
  • Quest Diagnostics' Free Cash Flow's 5-year high stood at $645.0 million during Q1 2021, with a 5-year trough of -$33.0 million in Q1 2023.
  • Over the past 3 years, Quest Diagnostics' median Free Cash Flow value was $268.0 million (recorded in 2024), while the average stood at $256.8 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 107.91% in 2023, then surged by 294.00% in 2025.
  • Quest Diagnostics' Free Cash Flow (Quarterly) stood at $337.0 million in 2021, then tumbled by 44.51% to $187.0 million in 2022, then spiked by 143.32% to $455.0 million in 2023, then declined by 25.05% to $341.0 million in 2024, then skyrocketed by 67.60% to $419.0 million in 2025.
  • Its last three reported values are $419.0 million in Q3 2025, $436.0 million for Q2 2025, and $197.0 million during Q1 2025.